News

Transposon Announces Final Results from a Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia

TPN-101 treatment reduced the rate of decline of Vital Capacity by 50% compared to placebo after 24 weeks, an objective respiratory measure that correlates...

Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity

CBDL’s Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products’ Projected 2025 Sales Revenues to Reach $1.8 Million

SCOTTSDALE, AZ / ACCESSWIRE / July 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The...

Beyond “One Bug, One Drug” – Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

The Broken Brown Egg and Progyny Announce the 2024 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc (Nasdaq: PGNY), a transformative fertility, family building, and women’s health...

error: Content is protected !!